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A PKA consensus phosphorylation site S1928 at the α11.2 subunit of the rabbit cardiac L-type channel, CaV1.2, is involved in the
regulation of CaV1.2 kinetics and aﬀects catecholamine secretion. This mutation does not alter basal CaV1.2 current properties
or regulation of CaV1.2 current by PKA and the beta-adrenergic receptor, but abolishes CaV1.2 phosphorylation by PKA. Here,
we test the contribution of the corresponding PKA phosphorylation site of the human α11.2 subunit S1898, to the regulation of
catecholamine secretion in bovine chromaﬃn cells. Chromaﬃn cells were infected with a Semliki-Forest viral vector containing
either the human wt or a mutated S1898A α11.2 subunit. Both subunits harbor a T1036Y mutation conferring nifedipine
insensitivity. Secretion evoked by depolarization in the presence of nifedipine was monitored by amperometry. Depolarization-
triggered secretion in cells infected with either the wt α11.2 or α11.2/S1898A mutated subunit was elevated to a similar extent
by forskolin. Forskolin, known to directly activate adenylyl-cyclase, increased the rate of secretion in a manner that is largely
independent of the presence of S1898. Our results are consistent with the involvement of additional PKA regulatory site(s) at the
C-tail of α11.2, the pore forming subunit of CaV1.2.
1.Introduction
The voltage-gated calcium channels (VGCCs) are regulated
by kinases that are activated by second messenger pathways
[1–4]. The dihydropyridine-sensitive VGCC, known as the
L-type channel or CaV1.2, is modulated by protein kinase A
(PKA) and protein kinase C (PKC) [4]. The β-adrenergic re-
ceptor activates cAMP-dependent phosphorylation by PKA,
which increases the amplitude of voltage-dependent Ca2+
currents. It is now well established that the β-adrenergic sig-
nalingenhancesinwardCa2+ currentsviaCaV1.2phosphory-
lation in cardiac myocytes [2, 4–6], adrenal chromaﬃnc e l l s
[7, 8], rat hippocampal neurons [9] and in skeletal muscle
[10].
PKA phosphorylation of the L-type channel leads to an
increase in the open probability (Po)o ft h ec h a n n e l[ 5]a n d
an increase in the mean open time by augmenting the num-
beroflongopenings [11].Intheheartactivationoftheβ-ad-
renergic signaling pathways increases calcium currents ∼4-
fold and is attributed to the phosphorylation of CaV1.2[ 12].
The L-type channel assembles with Gs, adenylyl cyclase,
PKA, and phosphatase PP2A into a signaling complex that
enables the rapid modulation of the channel by the adren-
ergic receptor [13]. Biochemical studies in the heart have
shown that the distal C-terminal tail of the α11.2 subunit is
phosphorylated by PKA on serine 1928 (S1928) [14–17].
Phosphorylation of S1928 in cardiac and neuronal cells im-
plies β-adrenergic regulation of CaV1.2[ 4, 17–21].
The phosphorylation of S1928, the PKA consensus phos-
phorylation site at the α11.2 pore forming subunit of rabbit
CaV1.2 that is phosphorylated both in vitro and in vivo,w a s
suggested to be responsible for the increase in Ca2+ currents
[19].
Additionalphosphorylationsitesthatcanalsoparticipate
in the β-adrenergic regulation of cardiac L-type Ca2+ chan-
nels [16] include the intracellular β-subunit of the channel
[22, 23]. Since S1928 is phosphorylated also by PKC, it was
suggested that both PKA and PKC signaling pathways con-
verge at S1928 of the α11.2 subunit to increase channel acti-
vity [24].2 International Journal of Endocrinology
More recently, the regulation of CaV1.2 by the β-adre-
nergic pathway in mouse heart was tested in vivo using
knock-inmousewithatargetedmutationofS1928toalanine
[25]. This mutation, which abolished PKA phosphorylation
of S1928, did not aﬀect the kinetic characteristics and the β-
adrenergic regulation of the L-type current. The conclusion
led to the suggestion that PKA phosphorylation of S1928 in
cardiomyocytes is functionally not involved in the β-adren-
ergic stimulation of CaV1.2-mediated calcium inﬂux [25].
In neuroendocrine cells such as bovine chromaﬃna n d
PC12 cells, membrane depolarization triggers catecholamine
(CA) secretion primarily by the opening of the L-type chan-
nels [26–28]. In these cells, the channel is an integral part of
the signaling complex that triggers secretion [29–32]. Vol-
tage-driven perturbations of a Ca2+-bound channel were
suggested to transmit the signal from the channel to the exo-
cytotic machinery and trigger fast release of vesicles assem-
bled with the channel [28, 31, 33–35]. Therefore, channel
phosphorylation would be expected to modify secretion. As
previously shown, inhibitors of protein phosphorylation or
injection of phosphatase 2A into cells suppresses facilitation
ofdepolarization-evokedsecretion[7].Basedontheseresults
it was suggested that facilitation is mediated by phosphory-
lation of voltage-dependent L-type Ca2+ channel [8].
We examined the modulation of L-type channel and its
role in mediating evoked secretion using forskolin. Secretion
was triggered in cells infected with the human wt α11.2
(Hu/wt) or α11.2/S1898A (Hu/S1898A) mutant subunit. The
S1898 site corresponds to S1928 of rabbit cardiac cells. The
frequency of the secretory events mediated by Hu/S1898A
and Hu/wt-infected cells was accelerated by forskolin to a
similar extent, indicating that mutating serine 1898 to ala-
nine did not aﬀect the forskolin-induced increase of cate-
cholamine secretion.
Overall, our results suggest that additional PKA-sensitive
phosphorylation sites contribute to the PKA modulation of
catecholamine release.
2.ExperimentalProcedures
2.1. Materials and Methods. T h ec o m p l e t eh u m a nc D N A so f
α11.2subunit,accessionnumberAJ224873,rabbitβ2b acces-
sion number X64298, and rabbit α2/δ accession number
NM 001082276, were kindly donated by Dr. M. Sanguinetti
(University of Utah). A modiﬁed pSFV1 (Invitrogen) plas-
mid, where an internal ribosome entry site from poliovirus
had been inserted followed by the gene for enhanced GFP,
was provided by Dr. U. Ashery.
Mutagenesis. Standard methods of plasmid DNA prepara-
tion were used to prepare the human α11.2/S1989A. The
CaV1.2α1subunit coding sequence (AJ224873) was used as a
template. The S1898A mutation was introduced by mutating
the codon TCC to GCC by using the Bio-X-Act Long DNA
Polymerase kit (Bioline, Israel) and Quick-change site-dir-
ected mutagenesis PCR was applied (Bioline, Israel).
The following primers were used: 5 -TGCCTCACTAGG-
TCGAAGGGCCGCCTTCCACCTGGAATGTCTGAA and
the 3 -TTCAGACATTCCAGGTGGAAGGCGGCCCTT-
CGACCTAGTGAGGCA. For amperometry studies, plas-
mids α11.2/T1036Y and α11.2/S1898/T1036Y were inserted
upstream of the internal ribosome entry site using BamHI
and BssHII restriction sites. All constructs were veriﬁed by
DNA sequencing and restriction site mapping.
2.1.1. Chromaﬃn Cell Preparation and Culture. Bovine adre-
nal glands were obtained at a local slaughterhouse. The adre-
nalmedullacellswereisolatedaspreviouslydescribedin[34]
andplat edatadensityof5×104 cells/cm2onglasscoverslips
placed in 35mm plates, in DMEM (Gibco) supplemented
with ITS-X (Sigma, Israel). Cells were incubated at 37◦Ci n
5% CO2 and were used for amperometric recordings 1–4
days after preparation at 23◦C.
2.1.2.AmperometricRecordingsofCatecholamineReleasefrom
ChromaﬃnC e l l . Amperometry recordings were carried out
using 5μm thin carbon ﬁber electrodes (CFE ALA Incorp.
Westbury, NY, USA) and a VA-10 ampliﬁer (NPI-electronic,
Tamm, Germany) held at 800mV as described previously
[36]. Cells were rinsed 4 times prior to the experiment and
bathed during the recordings at 23◦C in isoosmotic physi-
ological solution (149mM NaCl, 2mM KCl, 1mM MgCl2,
2mMCaCl 2, 10mM Glucose, and 10mM HEPES, pH 7.3 at
∼23◦C (adjusted with NaOH)). Individual cells were stim-
ulated to release by a 10sec application of isoosmotic 60mM
KCl buﬀer from a ∼3μm tipped micropipette placed 5–7μm
from the cell in the bath. Amperometric currents were sam-
pled at 10kHz, using clampex 9.2 (Axon Instruments) and
low-pass ﬁlter at 1kHz.
Secretionofcatecholaminesfromﬂuorescentcellsidenti-
ﬁed at 480nm excitation was recorded 16–24 hrs after infec-
tion by amperometry.
2.1.3. pSFV Infection
V i r u sP r e p a r a t i o na n dI n f e c t i o n . Recombinant SFV particles
were generated as described previously in [37]. Brieﬂy, in
vitro transcribed RNA from pSFV-GFP, or pSFV express-
ing GFP through an internal ribosome entry site (IRES)
motif, pSFV-Nifedipine-insensitive α11.2-IRES-GFP, or
pSFV-Nifedipine-insensitive α11.2/S1898A-IRES-GFP was
coelectroporated into BHK-21 cells with pSFV-Helper-2
RNA. Virus stocks were harvested 24hr later and activated
with alpha-chymotrypsin before infection studies. Approxi-
mate titers were estimated by infection of known numbers of
BHK-21 cells with serial dilutions of SFV stocks, and the
GFP-positivecellswerecounted.Generally,titersintherange
of 5 × 108 infectious particles/mL were obtained.
SFV particles (30μL/dish) were added to the cultured
cells(2 ×105 cellsperdish)5–48hafterplating.Infectedcells
were identiﬁed by their GFP ﬂuorescence.
2.1.4. Amperometric Data Acquisition and Analysis. Rates of
secretion were determined for individual cells and averaged.
Spike frequencies were quantiﬁed for individual cells by
the slopes of the cumulative events during 10sec of KClInternational Journal of Endocrinology 3
stimulation and a 20sec poststimulus period (10–40sec) and
were averaged to obtain a cell mean. The rate of secretion
during 10–40sec was determined from the slopes of the cor-
responding cumulative spike plots. Data was analyzed as des-
cribed in the text and ﬁgure legends. Error bars give standard
errors. Spikes exceeding three times the background noise
(>10pA) were analyzed. All peaks identiﬁed by the program
IGOR PRO (Wavemetrics, Lake Oswego, Or, USA) were in-
spected visually and bad signals were excluded manually.
2.1.5. Expression in Xenopus Oocytes and cRNA Injection.
Stage V-VI Xenopus laevis oocytes were removed surgically
from the ovaries of anesthetized animals and transferred to a
Ca2+-free medium (96mM NaCl, 2mM KCl, 1mM MgCl2,
and 5mM HEPES, pH7.4) containing 1mg/mL collagenase
(253U/mg) (Wortington Bioche. Corp. USA). The follicular
cell layer was removed by shaking the oocytes in this buﬀer
for 1.5–2hr at room temperature. After extensive wash, the
oocytes were transferred to ND96 buﬀer (96mM NaCl,
3mM KCl, 1mM MgCl2,1 . 8m MC a C l 2, and 5mM HEPES,
pH7.4) containing 2.5mM pyruvate, 100U/mL penicillin,
and 10μg/mL streptomycin. Oocytes were incubated in
ND96 for 12–20hr before cRNA injection.
2.1.6. cRNA Injection into Oocytes and Electrophysiology.
cRNAs were prepared using the T7 Fermentas transcription
kit (Lituania), and the product was monitored by gel electro-
phoresis and optical density measurements. In vitro tran-
scribed capped cRNA of the channel subunits were injected
into the defolliculated oocytes in a ﬁnal volume of 40nL
using a Drummond 510 microinjector (Broomall, Pa, USA).
Oocytes were maintained at 18◦C for 5 days after injection
[30].
2.1.7. Confocal Imaging. Single optical sections through the
oocytes were obtained with an Olympus FV1000 (Olympus,
Japan) equipped with a 40x oil objective (N.A. 1.3). Two
excitation lasers were used sequentially: 488nm GFP and
narrow-band emission ﬁlters 505–525nm. Sequential scan-
ning was performed with a resolution set to 512 × 512 pixels
(0.621mm/pixel), and single optical sections ∼0.5μm thick
were captured. Exposure time was 8μsec/pixel.
3. Results
3.1. Mutated α1 Subunit Is Targeted to the Cell Membrane.
The sequence homology of the phosphorylation consensus
site of S1928 at the distal C-terminal of the α11.2 pore form-
ing subunit corresponds to S1898 in the human α11.2, as
shown in Figure 1(a). This highly conserved sequence in
various species represents a PKA consensus phosphorylation
motif (Figure 1(b)).
The consensus S1898 of the human α11.2 subunit was
mutated to Ala and inserted into a frog expression vector.
The cRNAs encoding the GFP-tagged human α11.2 subunit
of CaV1.2 or the GFP-α11.2/S1898A mutant were coinjected
into oocytes along with the cRNAs encoding the auxiliary
rabbitα2δ andβ2bchannelsubunits(seeSection 2).Oocytes
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Figure 1: Membrane targeting of α11.2 and α11.2/S1898A to the
membrane. (a) Schematic view of the α11.2 pore forming subunit
of CaV1.2. (b) A comparison of the protein kinase A (PKA) consen-
sus sequence of the highly conserved Ser located at the distal C-ter-
minal of α11.2 of various species. (c) The human GFP-α11.2
(7ng/oocyte) and the GFP-α11.2/S1898A (7ng/oocyte) were inject-
edintoXenopus laevis oocytestogetherwiththeβ2b(2.5ng/oocyte)
and α2δ (5ng/oocyte). Five days later the oocytes were imaged
by confocal microscopy. Membrane targeting and expression of
the channels to the membrane were determined by calculating the
pixel/area.
imaged by confocal microscopy showed a similar mean
gray value for both channels, indicating nearly identical
level of protein expression and targeting to the membrane
(Figure 1(c)).
3.2. Depolarization-Induced Secretion in Bovine Chromaﬃn
Cells Is Largely Mediated by CaV1.2 a n dI sN o tA ﬀected by
the Viral Infection. Modulation of catecholamine secretion
mediated by human α11.2 subunit was tested in bovine
chromaﬃn cells.4 International Journal of Endocrinology
At ﬁrst, using a selective CaV1 channel blocker, we con-
ﬁrmed that depolarization-evoked release is mediated pri-
marily by the L-type channel (Figure 2(a)). The evoked
release was signiﬁcantly inhibited by 5μm nifedipine present
in the bath (Figure 2(a) inset). Averaged time courses of exo-
cytosis in the absence and in the presence of 5μM nifedipine
are shown by the cumulative histograms (Figure 2(a), upper
right). Spike frequencies were quantiﬁed for individual cells
as initial rates, which correspond to the linear ﬁts to the
averaged cumulative histograms (bold lines) collected from
cells (n = 49) during the 10sec of 60mM KCl (K60) stim-
ulation and a 20sec poststimulus period (range 10–40sec)
(Figure 2(a), lower right).
We then tested the eﬀect of Semliki Forest virus (SFV)
infection on the rate of secretion in cells using SFV viral vec-
torharboringGFP,aspreviouslydescribed[28].Theinfected
ﬂuorescent cells that were visualized using UV detection
weredepolarizedbyK60for10secandcatecholaminerelease
was monitored as amperometric spikes using carbon ﬁber
electrode, where each spike represents the release of a single
vesicle [36, 38]. Secretion from the ﬂuorescent cells was
monitored 16–24 hrs after infection. The extent of release
was hardly aﬀected by the infection procedure as seen in the
amperometric traces (Figure 2(b)) consistent with previous
studies [28, 37]. Evoked secretion was signiﬁcantly decreased
in the presence of nifedipine, in GFP-infected cells, similarly
to noninfected cells (Figure 2(b) inset). The overall time
course of secretion determined from the normalized waiting
time distributions was 0.52 spike/sec in the GFP-infected
cells (Figure 2(b), lower) and 0.53 spike/sec in noninfected
cells (Figure 2(a), lower). No release was detected when the
cells were stimulated in a Ca2+-free solution (Figure 2(c),
left) or in the absence of K60 (Figure 2(c), right).
3.3. The Kinetic Parameters of Amperometric Spikes and Foot
in Cells Infected with GFP- and the wt Human α11.2 (Hu/wt).
To study secretion mediated by the human channel, we
created a pSFV vector expressing wt α11.2 human channel
subunit (Hu/wt). As a control we monitored the kinetics of
secretioninducedincellsthatwereinfectedwithpSFVvector
expressing GFP (see above). Secretion mediated by the wt
α11.2(Hu/wt) pSFV vector was monitored in the presence
of 5μM nifedipine. The nifedipine insensitivity was used to
distinguish between the endogenous cellular channels and
our cloned channels that were made resistant to nifedipine
(Nif) by a single-amino-acid mutation, T1036Y [39]. The
T1036Y mutation rendered the channels completely imper-
meable to calcium ions as previously shown in HEK 293 cells
and in Xenopus oocytes [28, 39]. Diﬀerences between the
spike and pre-spikes (foot) kinetics elicited in GFP-infected
and the Hu/wt-infected cells indicate diﬀerences between
bovine and human CaV1.2. Representative amperometric
spikes elicited by a 10sec pulse of K60 from single GFP- and
in Hu/wt-infected cells are shown in Figure 3(a). The kine-
ticparametersofamperometriccurrents,includingpeakam-
plitude, half-width, 50–90% rise time, and integrated spike
(Q, gray area)a sw e l la sf o o tw i d t h ,f o o ta m p l i t u d e ,a n d
integrated foot (Q, white area), are presented schematically
in Figure 3(b). The amperometric currents were quantiﬁed
analyzing the distribution of the data depicted as cumulative
probability in the GFP and the Hu/wt channel subunit
(Figures 3(c)–3(f)). For every parameter, the values from
each cell were averaged and presented as the mean of cell
averages ± the standard error of the mean (SEM) for each
group [40]. The kinetic parameters of spikes including spike
amplitude, 50–90% rise time, and mean-charge, were similar
while the spike half-width was slightly higher in Hu/wt
(Figures 3(e) and 3(f)).
The foot amplitude and the kinetics of foot width were
not signiﬁcantly diﬀerent, calculated by analyzing the distr-
ibution of the data and depicted as cumulative probability
in the GFP- and the Hu/wt-infected cells (Figures 3(g) and
3(h)).
3.4. The Kinetic Parameters of Amperometric Spike and Foot
Elicited by Human wt and Mutated S1898A Channels. The
α11.2 (Hu/wt) or the α11.2/S1898A (Hu/S18989A) subunits
that harbored a second mutation T1036Y that rendered the
channel nifedipine insensitive were subcloned into a pSFV,
which expresses GFP through an internal ribosome entry site
(IRES) motif [28]. Both Hu/wt and the mutated Hu/S1898A
subunits, which included GFP, were made dihydropyridine
insensitive and enabled discrimination of secretion mediated
by exogenously expressed human channels from that of
nativebovinecalciumchannels[28,39].Wetestedthekinetic
parameters of cells infected with either Hu/wt or Hu/S1898A
subunits in the presence of 5μM nifedipine, 16–24 hrs after
infection as shown by representative amperometric currents
(Figures 4(a) and 4(b)). The amperometric spikes elicited in
the Hu/wt, and Hu/S1898A-infected cells were quantiﬁed by
analyzing the distribution of the data, depicted as cumulative
probability (Figures 4(c)–4(f); see also Figure 3). For every
parameter, the values from each cell were averaged and
presented as the mean of cell averages ± the standard error
of the mean (SEM) for each group [40]. The mutation of
Ser 1898 to Ala, which prevents the phosphorylation at this
site, enabled the examination of the net eﬀect of this site
on the kinetics of spike and foot parameters. The mutation
did not aﬀect spike and foot kinetics as shown by the mean
distribution of peak amplitude, half-width, charge, or
50−90% rise-time (Figures 4(c)–4(f)).
In addition, foot values that correspond to the pre-spike
signal and depict the properties of the fusion pore [41] did
not show any signiﬁcant changes in the mean distribution of
the cumulative events (Figures 4(g) and 4(h)).
3.5. Forskolin Increases the Rate of Secretion. It has previously
been shown that S1928 is phosphorylated by PKA, both in
vitro and in vivo, either directly by β-adrenergic agonists or
indirectly by forskolin [14, 15].
To gain insight into the speciﬁc contribution of the
corresponding consensus PKA site S1898 to the regulation
of catecholamine release mediated via CaV1.2, we applied
forskolin to cells infected with Hu/wt and Hu/S1898A.
The eﬀect of forskolin on secretion was tested at ﬁrst, on
GFP-infected cells. As shown by the amperometric currentsInternational Journal of Endocrinology 5
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Figure 2: Amperometry measurements of catecholamine release in bovine chromaﬃn cells. (a) Traces of amperometry currents elicited in
noninfected chromaﬃn cells by a 10sec puﬀ of 60mM KCl (K60) as indicated by the arrow (left), and in the presence of 5μM nifedipine
(inset). The cumulative number of events per cell (n = 18), averaged with and without 5μM nifedipine, was plotted versus time (right).
An expanded view of the initial cumulative spike counts (lower, left) and the initial rate of secretion calculated from the linearization of the
cumulative averaged spike count (0.53 ± 0.02spike/sec; lower, right). (b) Traces of amperometry currents elicited by a 10sec puﬀ of 60mM
KCl (K60) in cells infected with pSFV containing GFP (left) and in the presence of 5μM nifedipine (inset). The cumulative number of events
per cell was averaged (n = 49) with and without 5μM nifedipine and plotted versus time (right). An expanded view of the initial cumulative
spike counts (lower, left) and the initial rate of secretion calculated from the linearization of the cumulative averaged spike count (0.52 ±
0.01spike/sec; lower, right). (c) Bovine chromaﬃn cells stimulated under the same experimental conditions as above in nominally Ca2+ free
solution (left) or stimulated with isoosmotic solution containing 2mM KCl a sham stimulation (right).6 International Journal of Endocrinology
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Figure 3: The kinetics of spike and foot parameters elicited in GFP- and human-wt α11.2-(Hu/wt-) infected cells are similar. (a) Amper-
ometric currents representing single-vesicle events were triggered by a 10sec pulse of K60 in cells infected with pSFV containing GFP or
Hu/wt in the presence of 5μM nifedipine. (b) The kinetic properties of a single amperometric event: peak amplitude, half-width, 50–90%
rise time, and integrated spike (Q, grayarea). Foot signal: foot-width, foot-amplitude, and integrated foot (Q, whitearea). (c) Cumulative
distribution plots of spike number and analysis of peak amplitude induced in GFP- or Hu/wt-infected cell; (inset), mean values for peak
amplitude n = 1048, n = 943 events per data point, respectively. (d) Cumulative distribution plot of spike number and analysis of 50–90%
rise time detected in GFP- and Hu/wt-infected cells. Data plotted in a similar fashion as in (c); mean values for 50–90% rise time (inset). (e)
Cumulative distribution plot of spike number and analysis of half-width in GFP- or Hu/wt-infected cells (inset), mean values for spike half-
width (f) Cumulative distribution plot of spike number and analysis of mean charge in GFP- or Hu/wt infected cells; (inset), mean values for
spike mean charge. (g) Cumulative distribution plot of foot number and analysis of foot amplitude in GFP- or Hu/wt-infected cells (inset),
mean values for foot amplitude. (h) Cumulative distribution plot of foot number and analysis of foot width in GFP- or Hu/wt-infected cells
(inset), mean values for foot width ∗P<0.05.International Journal of Endocrinology 7
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Figure 4: Spike and foot parameters of Hu/wt are not aﬀected by the S1898A mutation. Amperometric current triggered in the presence of
5μM nifedipine by a 10sec pulse of K60 as indicated by the arrow. (a) Representative single amperometric events triggered in cells infected
with Hu/wt subunit (n = 43) or (b) Hu/S1898A (n = 42). (c) Cumulative distribution plot of spike number and analysis of peak amplitude
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Table 1: The eﬀect of forskolin on the rate and total catecholamine secretion. The rate of secretion was determined in cells infected with
GFP, Hu/wt, the wt human α11.2 subunit, and Hu/S1898A, and the mutant α11.2/S1898A subunit.
Group # Cells # Spikes AVG
# Spikes
Frequency Secretion
10–40sec
(Spike/sec) Fold 10–40sec
(pC) Fold
Noninfected 18 502 27 ± 4.8 0.53 ± 0.02
R2 = 0.995 15.4 ± 1.8
GFP 49 1048 21.4 ± 3.0 0.52 ± 0.01
R2 = 0.989 16 ± 2.5
GFP + FSKa 21 693 33 ± 3.2 0.79 ± 0.03
R2 = 0.994 1.5 26 ± 4.4∗ 1.6
Hu/wt 43 943 22 ± 2.5 0.57 ± 0.02
R2 = 0.989 17 ± 1.9
Hu/wt + FSK 34 1052 30 ± 4.9 0.86 ± 0.03
R2 = 0.982 1.5 28 ± 4.5∗ 1.6
Hu/S1898A 42 547 13 ± 1.4 0.35 ± 0.01
R2 = 0.995 10 ± 0.9
Hu/S1898A
+FSK 40 953 23.8 ± 3.5 0.46 ± 0.01
R2 = 0.985 1.3 16 ± 2.1∗ 1.6
Cells were stimulated for 10sec by 60mM KCl. Amperometric currents were measured during time range of 10–40sec, which includes the 10sec K60
stimulation and a 20sec poststimulus period.
a1μM forskolin (FSK);∗P<0.05.
(Figure 5(a)), 1μM forskolin when applied to GFP-infected
cells increased the frequency of the amperometric events.
The analysis of cumulative spikes showed an increase from
21 ± 3t o3 3± 3.1 spikes/cell (Table 1) and a 1.5-fold in-
crease in the initial rate from 0.52 ± 0.01 to 0.79 ± 0.03
spike/sec (Figure 5(c) left). The increase in the frequency of
the amperometric events induced by forskolin also led to
a 1.6-fold increase in total catecholamine secretion, which
was calculated as the total mean charge of spike area
within the range of 10–40sec during and after stimulation
(Figure 5(c) right; Table 1).
Next, we compared the eﬀect of forskolin on secretion
mediated by the Hu/wt or Hu/S1898A. Shown by represen-
tative amperometric traces, forskolin accelerated the rate of
secretion in cells infected with either Hu/wt or Hu/S1898A
(Figure 6(a)). The increase in the frequency of the amper-
ometric spikes induced by forskolin was quantiﬁed as des-
cribed above (see Figure 2). In both the GFP- and Hu/wt-
infectedcells,therateofsecretionwasincreased1.5-fold,and
in the Hu/S1898A-infected cells 1.3-fold (Figures 6(a) and
6(b) and Table 1). Forskolin increased the total release of
catecholamine to a similar extent (1.6-fold), in the GFP-,
Hu/wt-, or Hu/S1898A-infected cells, as summarized in the
bar graph (Figure 6(c))a n dTable 1.
Forskolininducedasimilarupregulationofreleaseevents
mediated by the human Hu/wt and the endogenous bovine
channel (measured in cells infected with GFP). A smaller in-
crease (1.3-fold compared to 1.5-fold) was observed in Hu/
S1898A-infected cells.
3.6.TheEﬀectsofForskolinontheKineticsoftheAmperometric
Spikes and Foot. In spite of the increase in the frequency of
secretion by forskolin, no eﬀect on the kinetics of the indi-
vidual amperometric spikes and prespikes (foot) was observ-
ed, as presented in Table SI of the supplementary material
available online at doi:10.1155/2011/746482.
4. Discussion
4.1.TheContributionofS1898totheRateofSecretioninChro-
maﬃnC e l l s . In bovine chromaﬃn cells membrane depolar-
ization triggers catecholamine release primarily via the acti-
vation of the dihydropyridine-sensitive VGCC, known as the
L-type channel. This was previously shown using selective
DHPL-typechannelblockers[26,28].TheactivityofCaV1.2
like other VGCC is further modulated by phosphorylation
[2, 4].
Phosphorylation of the L-type channel or CaV1.2b y
protein Kinase A (PKA) and protein kinase C (PKC) further
modulates the kinetics of the channel [4]. Biochemical stud-
ies in the heart and in neuronal cells have shown that the dis-
tal C-terminal tail of the α11.2 subunit is phosphorylated by
PKA on serine 1928 (S1928) [14–17]. This consensus phos-
phorylation site corresponds to S1898 in the human CaV1.2,
and here we have tested whether this site at the human
pore forming α11.2 subunit contributes to the regulation of
catecholamine release in bovine chromaﬃn cells.
At ﬁrst we conﬁrmed that bovine chromaﬃn cells infect-
edwithpSFVvectorcontainingGFPretainedtheirsensitivity
to nifedipine. Secretion of CA that was monitored using car-
bon ﬁber amperometry was reduced by more than 85%.
Both the human wt α11.2 (Hu/wt) and the α11.2/S1898A
(Hu/S1898A) subunits, which are equally expressed and tar-
geted to the cell membrane, were introduced into chromaﬃn
cells via Semliki forest viral infection. The two channelInternational Journal of Endocrinology 9
200
150
100
50
0
200
150
100
50
0
0 2 04 06 0
Time (s)
0 20 40
Time (s)
20 40 60
K60 K60
I
A
m
p
(
p
A
)
I
A
m
p
(
p
A
)
GFP + FSK GFP
(a)
0
10
20
30
40
100 20 40 60 80 0
0
10
20
30
01 0 2 0 3 0 4 0
Time (s) Time (s)
GFP GFP
K60
N
u
m
b
e
r
o
f
e
v
e
n
t
s
N
u
m
b
e
r
o
f
e
v
e
n
t
s
GFP + FSK GFP + FSK
(b)
0
1
0.5
I
n
i
t
i
a
l
r
a
t
e
(
s
p
i
k
e
/
s
)
0
10
20
30
I
n
i
t
i
a
l
s
e
c
r
e
t
i
o
n
(
p
C
)
GFP GFP GFP + FSK GFP + FSK
(c)
Figure 5: The eﬀect of forskolin on GFP-infected chromaﬃn cells. Amperometry currents were elicited by a 10sec puﬀ of 60mM KCl (K60)
in GFP-infected cells in the presence of 1μM forskolin, as indicated by the arrow. (a) Representative single amperometric events of GFP-
infected cells with (n = 21) or without forskolin (n = 49). (b) The cumulative number of events per cell averaged for GFP-infected cells
with or without forskolin was plotted versus time (left). An expanded view of the initial cumulative spike counts plotted versus time (right).
(c) The initial rate of secretion calculated from the linearization of the cumulative averaged spike count (left). Means were calculated for
individual cells as an average of more than 500 spikes; see Table 1. The total amount of catecholamine secreted was quantiﬁed by averaging
of the total mean charge. Summation of spike areas in cells infected with GFP during time range of 10–40sec, which includes the 10sec K60
stimulation and a 20sec poststimulus period (right); ∗P<0.05.10 International Journal of Endocrinology
400
350
300
250
200
150
100
50
0
200
150
100
50
0
0 1 02 03 04 05 06 0
Hu/wt Hu/wt + FSK Hu/S1898A Hu/S1898A + FSK
Time (s)
02 0 4 0 8 0 60
Time (s)
02 0 4 0 8 0 60
Time (s)
I
A
m
p
(
p
A
)
200
150
100
50
0
02 0 4 0 6 0
Time (s)
I
A
m
p
(
p
A
)
I
A
m
p
(
p
A
) 200
250
150
100
50
0
I
A
m
p
(
p
A
)
K60 K60 K60 K60
(a)
40
30
20
10
0
0 2 04 06 08 0 1 0 0
Time (s)
Time (s) Time (s)
Time (s)
FSK FSK
30
20
10
0
40 30 20 10 0
FSK
30
20
10
0
40 30 20 10 0
Hu/wt
FSK
Hu/wt Hu/S1898A Hu/S1898A
40
30
20
10
0
0 2 04 06 08 0 1 0 0
Hu/S1898A
Linear ﬁt of Dat40 Hu/wt
Linear ﬁt of Dat40 FSK
Linear ﬁt of Dat40
Linear ﬁt of Dat40 FSK
K60 K60
N
u
m
b
e
r
o
f
e
v
e
n
t
s
N
u
m
b
e
r
o
f
e
v
e
n
t
s
N
u
m
b
e
r
o
f
e
v
e
n
t
s
N
u
m
b
e
r
o
f
e
v
e
n
t
s
(b)
1
0.5
0
Hu/wt +FSK Hu/S1898A +FSK
I
n
i
t
i
a
l
r
a
t
e
(
s
p
i
k
e
/
s
) 30
20
10
0
Hu/wt +FSK Hu/S1898A +FSK
I
n
i
t
i
a
l
 
s
e
c
r
e
t
i
o
n
 
(
p
C
)
(c)
Figure 6: Forskolin accelerates secretion to the same extent in Hu/wt- and Hu/S1898A-infected cells. Amperometry currents were elicited
by a 10sec puﬀ of 60mM KCl (K60) as indicated by the arrow, in chromaﬃn cells infected with pSFV containing Hu/wt (left) or Hu/S1898A
(right)inthepresenceof1μMforskolinand5μMnifedipine.(a)RepresentativesingleamperometriceventsinHu/wtorHu/S1898Ainfected
cells, with and without forskolin. (b) The cumulative number of events per cell averaged for Hu/wt- and Hu/S1898A-infected cells (n = 49
and n = 42), with or without forskolin (n = 43 and n = 40), was plotted versus time. An expanded view of the initial cumulative spike
counts plotted versus time (lower). (c) The initial rates of secretion were calculated from the linearization of the cumulative averaged spike
count (left). Means were calculated for individual cells as an average from more than 500 spikes; see Table SI. Total amount of catecholamine
secreted was quantiﬁed by averaging of the total mean charge. Summation of spike areas in cells infected with Hu/wt (empty columns) or
Hu/S1898A (gray columns) during time range of 10–40sec (right); ∗P<0.05.International Journal of Endocrinology 11
subunitseachharboredanadditionalmutationthatrendered
them nifedipine insensitive. Secretion in the infected cells
was carried out in the presence of nifedipine, which enabled
the functional discrimination of L-type-mediated secretion
contributed by exogenously expressed human channels from
that of native bovine Ca2+ channels. The frequency of secre-
tion and the total catecholamine released that was mediated
by the endogenous bovine channel was similar to that of the
human α11.2 (Hu/wt) channel. Also the spike parameters
and the prespike (foot) parameters were indistinguishable.
4.2. Forskolin Elevated Depolarization-Evoked Secretion Inde-
pendently of S1898. Protein microsequencing of phospho-
peptidemappingconﬁrmedthatphosphorylationoccursata
PKA site, at serine 1928 near the C-terminus of cardiac α11.2
[14]. Based on these results it was suggested that the single
PKA consensus site S1928 is involved in the β-adrenergic re-
ceptor modulation of channel activity.
Forskolin is known to activate adenylyl cyclase, which by
producing cAMP and activating PKA, leads to the phosphor-
ylation of the α1 subunits of the L-type channel thereby, up-
regulating its activity. It was previously shown that forskolin
elevation of cAMP could be fully accounted for by the acti-
vation of the β-adrenergic receptor [25, 42, 43]. Using for-
skolin, we tested the contribution of the human α11.2 sub-
unit to secretion by mutating Ser1898 to Ala, the site that
corresponds to the S1928 in rabbit cardiac α11.2 subunit.
The modulation of secretion by the PKA activation path-
way was tested by forskolin that was applied to chromaﬃn
cells infected with the Hu/wt or Hu/S1898A subunits.
The direct activation of adenylyl-cyclase by forskolin in
GFP-infected and in the Hu/wt-infected cells led to a similar
fold increase in the rate of depolarization-evoked secretion
andtotalcatecholaminerelease.Theseresultssuggestthatthe
human α1 subunitwasmostlikelyphosphorylatedbyPKAto
the same extent as the endogenous α1 subunit.
On the other hand, the positive impact of forskolin on
the rate of secretion was slightly lower in cells infected with
the Hu/S1898A subunit. These results suggest that forskolin
upregulates evoked secretion only marginally via S1898.
These results are in agreement with others [23]w h o
have demonstrated that the phosphorylation of S1928 in the
rabbit channel accounts only partially (∼20–30%) for the β-
adrenergic regulation of calcium currents in cardiomyocytes
[17]. Furthermore, in CaV1.2S1928-129B6F2 mice, no detectable
diﬀerences in heart rate were detected compared to control
animals during isoproterenol infusion [25]. It is predicted
that forskolin mediates phosphorylation through additional
site(s)eitherattheα11.2subunitorinotherchannelsubunits
[22,44]andonlymarginallythroughS1898.Previousstudies
have also shown that phosphorylation of this site involves
PKC [24].
In our studies, both the Hu/wt and the Hu/S1898A chan-
nel subunits mediate faster rate of secretion by forskolin.
Sincez forskolin modiﬁed secretion largely independently
of the presence of Ser or Ala at position 1898, we con-
cluded that the cAMP-dependent PKA has contributed to
the modulation of secretion via other selective sites [25].
Other studies have proposed that the cardiac L-type Ca2+
channels are phosphorylated in basal state by high levels
of PKA phosphorylation, while dephosphorylation reduces
their activity [19, 45].
Insummary,ourresultsshowthatmutatingS1898hardly
aﬀected the forskolin-induced increase in depolarization-
evoked secretion in the neuroendocrine cells. Given that a
similar forskolin-mediated increase in the rate of secretion
was observed in cells infected with Hu/wt and Hu/S1898A
mutant, our results indicate that other phosphorylation sites
either at the L-type channel auxiliary subunits or other pro-
teins of the secretory apparatus are involved in the upregula-
tion of depolarization-evoked secretion in chromaﬃn cells.
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